PubMed Health⌕ Search

PubMed · 7319709

On the relation between somatic evoked potentials and fields.

Abstract

Recently Okada et al. (1981) reported that stimulation of the median nerve with a brief electrical impulse at the wrist evoked a transient change in the brain's magnetic field. This somatic evoked field (SEF) is similar in its temporal waveform to the response to the same stimulus reported for the electrical potential recorded on the pial surface of the exposed brain. Moreover, both measures differ substantially from the somatic evoked potential (SEP) recorded at the scalp. The present paper describes a more detailed account of the SEF as well as an analysis of its relation to the SEP and to the somatic pial response (SPR). Its purpose of the use the three measures in clarifying our understanding of the nature and locations of sources of the SEF. This paper is divided into three sections. The first is a background section which reviews basic principles and models that are widely used in deducing the locations of sources of evoked potentials and fields. It indicates the types of currents which may give rise to the SEF, and distinguishes between them and the current which is associated with the SEP. It concludes with a rationale for the experiments described in the next section. The experiments described in the second section determined how the SEF varies with the position from which it is recorded at the scalp. These variations turn out to be essential to our understanding of the nature and location of the sources of the SEF. The third section summarizes the results of the experiments and makes clear how they affect theories of the origin of the SEF. The findings also have implications for our understanding of the SEP and SPR. The most salient findings are: (1) The SEF recorded normal to the head provides essentially the same information as that provided by reported potential recordings from the exposed surface of the brain (the SPR). (2) The SEF originates in the cortex of the cerebrum in the vicinity of the central sulcus. (3) The currents that account for identifiable components of the SEF are opposite in direction to those that account for corresponding components of the SPR. This result is consistent with models that ascribe the detected field normal to the scalp to intracellular currents, whereas the VEP is associated with extracellular currents flowing in the opposite direction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Kaufman, Y Okada, D Brenner, S J Williamson. 1981. On the relation between somatic evoked potentials and fields.. https://doi.org/10.3109/00207458108985860

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗